We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

AI Identifies Hidden Heart Valve Defects from Patient’s ECG

By HospiMedica International staff writers
Posted on 08 Aug 2025

Heart valve diseases, affecting over 41 million people globally, can lead to heart failure, hospitalization, and even death. More...

Early diagnosis is critical, yet symptoms like shortness of breath or dizziness are often misattributed, and some patients show no signs until the disease is advanced. Subtle changes in heart function, especially in its electrical activity, often go undetected until it’s too late. Researchers have now created an artificial intelligence (AI) tool to identify risk much earlier, using just a standard electrocardiogram (ECG).

Developed by researchers at Imperial College London (London, UK), the AI model uses a patient’s ECG to predict the risk of developing regurgitant valvular heart diseases. These conditions, which affect the mitral, tricuspid, or aortic valves, involve blood leaking backwards through the heart. The AI detects early structural changes in the heart that are not apparent to doctors, making it possible to flag high-risk patients earlier than ever before physical symptoms or damage appear.

The research team trained the algorithm on nearly one million ECG and echocardiogram records from over 400,000 patients in China. To ensure accuracy across populations, the tool was then validated on over 34,000 patients in the US, showing that it works well across ethnically diverse populations and healthcare systems. The study, published in The European Heart Journal, shows that the AI model successfully predicted valve disease risk 69–79% of the time, showing reliable performance across diverse ethnic groups and healthcare settings.

Additionally, high-risk patients identified by the AI were up to 10 times more likely to develop valve leakage, offering a critical window for prevention. This technology could revolutionize care by identifying patients in need of monitoring or early intervention, long before heart valve disease causes harm. The research follows on from the team’s development of the related AI-ECG risk estimation model, known as AIRE, which can predict patients’ risk of developing and worsening disease from an ECG.

“Our work is harnessing AI to detect subtle changes at the earliest stage from a simple and common test, and we think this could be really transformative for doctors and patients,” said Dr. Arunashis Sau, one of the study leads. "Rather than waiting for symptoms or relying only on expensive and time-consuming imaging tests, we could use AI-enhanced ECGs to spot those most at risk earlier than ever before."


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.